LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Return
10.14%
This Quarter Return
+4.35%
1 Year Return
+10.14%
3 Year Return
+35.76%
5 Year Return
+141%
10 Year Return
–
AUM
$1.06B
AUM Growth
-$4.21M
(-0.39%)
Cap. Flow
-$37.4M
Cap. Flow
% of AUM
-3.51%
Top 10 Holdings %
Top 10 Hldgs %
45.51%
Holding
2,880
New
227
Increased
1,384
Reduced
630
Closed
115
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.5M |
| 2 |
Aon
AON
|
+$3.2M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$2.57M |
| 4 |
Microsoft
MSFT
|
+$1.63M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.29M |
Top Sells
| 1 |
Oaktree Specialty Lending
OCSL
|
+$12.3M |
| 2 |
NVIDIA
NVDA
|
+$7.68M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$3.95M |
| 4 |
Apple
AAPL
|
+$3.6M |
| 5 |
Broadcom
AVGO
|
+$2.49M |
Sector Composition
| 1 | Technology | 17.21% |
| 2 | Financials | 12.25% |
| 3 | Healthcare | 6.29% |
| 4 | Communication Services | 4.39% |
| 5 | Consumer Discretionary | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Hertz
HTZ
$1.98B
| $5.17K | ﹤0.01% |
1,465
+330
| +29% | +$1.17K |
|
1977
ADT
ADT
$7.25B
| $5.17K | ﹤0.01% |
680
+314
| +86% | +$2.39K |
|
1978
Steven Madden
SHOO
$2.27B
| $5.16K | ﹤0.01% |
122
| – | – |
|
1979
Victoria's Secret
VSCO
$2.1B
| $5.14K | ﹤0.01% |
291
+202
| +227% | +$3.57K |
|
1980
Blackstone Mortgage Trust
BXMT
$3.36B
| $5.12K | ﹤0.01% |
294
-510
| -63% | -$8.88K |
|
1981
Innoviva
INVA
$1.22B
| $5.12K | ﹤0.01% |
312
+4
| +1% | +$66 |
|
1982
Procore
PCOR
$10.5B
| $5.11K | ﹤0.01% |
77
+54
| +235% | +$3.58K |
|
1983
NovaGold Resources
NG
$2.83B
| $5.1K | ﹤0.01% |
1,474
+171
| +13% | +$592 |
|
1984
US Physical Therapy
USPH
$1.23B
| $5.08K | ﹤0.01% |
55
-1
| -2% | -$92 |
|
1985
Cullinan Oncology
CGEM
$379M
| $5.08K | ﹤0.01% |
291
| – | – |
|
1986
Adaptive Biotechnologies
ADPT
$1.96B
| $5.05K | ﹤0.01% |
1,396
+634
| +83% | +$2.3K |
|
1987
Mitek Systems
MITK
$470M
| $5.05K | ﹤0.01% |
452
+39
| +9% | +$436 |
|
1988
Federal Realty Investment Trust
FRT
$8.78B
| $5.05K | ﹤0.01% |
50
-10
| -17% | -$1.01K |
|
1989
Embecta
EMBC
$885M
| $5.04K | ﹤0.01% |
403
-249
| -38% | -$3.11K |
|
1990
Grand Canyon Education
LOPE
$5.9B
| $5.04K | ﹤0.01% |
36
+4
| +13% | +$560 |
|
1991
GATX Corp
GATX
$6.11B
| $5.03K | ﹤0.01% |
38
+1
| +3% | +$132 |
|
1992
Kymera Therapeutics
KYMR
$3.34B
| $4.99K | ﹤0.01% |
167
+16
| +11% | +$478 |
|
|
SAGE
1993
DELISTED
Sage Therapeutics
SAGE
| $4.99K | ﹤0.01% |
459
+261
| +132% | +$2.84K |
|
1994
Pacira BioSciences
PCRX
$1.22B
| $4.98K | ﹤0.01% |
174
+30
| +21% | +$858 |
|
1995
Vicor
VICR
$2.3B
| $4.97K | ﹤0.01% |
+150
| New | +$4.97K |
|
1996
Stagwell
STGW
$1.37B
| $4.97K | ﹤0.01% |
729
+298
| +69% | +$2.03K |
|
1997
Euronet Worldwide
EEFT
$3.61B
| $4.97K | ﹤0.01% |
48
+2
| +4% | +$207 |
|
1998
Origin Bancorp
OBK
$1.11B
| $4.95K | ﹤0.01% |
156
+5
| +3% | +$159 |
|
1999
nCino
NCNO
$3.49B
| $4.94K | ﹤0.01% |
157
+72
| +85% | +$2.27K |
|
2000
Burford Capital
BUR
$2.84B
| $4.92K | ﹤0.01% |
+377
| New | +$4.92K |
|